Healthcare Realty Trust (NYSE:HR – Get Free Report) updated its FY 2026 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of 1.620-1.660 for the period, compared to the consensus EPS estimate of 0.280. The company issued revenue guidance of -.
Healthcare Realty Trust Price Performance
NYSE HR traded down $0.47 during midday trading on Friday, hitting $21.07. 2,679,734 shares of the company traded hands, compared to its average volume of 3,870,702. The company has a market cap of $7.30 billion, a PE ratio of -36.32 and a beta of 0.98. The company’s 50-day simple moving average is $20.54 and its 200-day simple moving average is $18.93. Healthcare Realty Trust has a 52 week low of $15.28 and a 52 week high of $22.04.
Healthcare Realty Trust (NYSE:HR – Get Free Report) last released its quarterly earnings results on Thursday, July 30th. The real estate investment trust reported ($0.13) EPS for the quarter, missing the consensus estimate of $0.40 by ($0.53). The company had revenue of $278.58 million during the quarter, compared to the consensus estimate of $271.60 million. Healthcare Realty Trust had a negative return on equity of 4.29% and a negative net margin of 17.34%.The company’s revenue was down 5.3% on a year-over-year basis. During the same period in the previous year, the firm posted $0.41 earnings per share. Healthcare Realty Trust has set its FY 2026 guidance at 1.620-1.660 EPS. On average, research analysts predict that Healthcare Realty Trust will post 1.63 earnings per share for the current year.
Healthcare Realty Trust Dividend Announcement
Wall Street Analyst Weigh In
HR has been the topic of a number of recent analyst reports. Raymond James Financial started coverage on shares of Healthcare Realty Trust in a report on Tuesday, June 16th. They issued an “outperform” rating and a $24.00 price target on the stock. Wells Fargo & Company increased their target price on shares of Healthcare Realty Trust from $19.00 to $21.00 and gave the company an “equal weight” rating in a research report on Monday, June 1st. Weiss Ratings lowered shares of Healthcare Realty Trust from a “hold (c)” rating to a “sell (d+)” rating in a report on Monday, May 4th. Cantor Fitzgerald upped their price target on Healthcare Realty Trust from $22.00 to $24.00 and gave the stock an “overweight” rating in a research report on Friday. Finally, UBS Group increased their price objective on Healthcare Realty Trust from $20.00 to $21.00 and gave the company a “neutral” rating in a report on Wednesday, July 8th. Four research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average target price of $21.89.
Read Our Latest Analysis on Healthcare Realty Trust
Insiders Place Their Bets
In other Healthcare Realty Trust news, CAO Amanda L. Callaway sold 25,767 shares of the company’s stock in a transaction that occurred on Tuesday, June 23rd. The shares were sold at an average price of $20.37, for a total transaction of $524,873.79. Following the transaction, the chief accounting officer owned 109,954 shares in the company, valued at approximately $2,239,762.98. This represents a 18.99% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Corporate insiders own 0.56% of the company’s stock.
Institutional Investors Weigh In On Healthcare Realty Trust
Large investors have recently made changes to their positions in the stock. Dynamic Technology Lab Private Ltd purchased a new position in Healthcare Realty Trust in the 1st quarter worth $205,000. Empowered Funds LLC acquired a new position in shares of Healthcare Realty Trust in the first quarter valued at about $202,000. Invesco Ltd. increased its holdings in shares of Healthcare Realty Trust by 48.9% in the second quarter. Invesco Ltd. now owns 2,307,109 shares of the real estate investment trust’s stock valued at $36,591,000 after purchasing an additional 757,542 shares during the period. First Trust Advisors LP raised its stake in shares of Healthcare Realty Trust by 314.1% in the second quarter. First Trust Advisors LP now owns 223,125 shares of the real estate investment trust’s stock worth $3,539,000 after purchasing an additional 169,248 shares during the last quarter. Finally, Amundi raised its stake in shares of Healthcare Realty Trust by 154.0% in the second quarter. Amundi now owns 519,816 shares of the real estate investment trust’s stock worth $8,343,000 after purchasing an additional 315,179 shares during the last quarter.
About Healthcare Realty Trust
Healthcare Realty Trust (NYSE: HR) is a real estate investment trust specializing in the ownership, acquisition and management of outpatient medical facilities. Headquartered in Nashville, Tennessee, the company’s portfolio is focused primarily on medical office buildings and outpatient healthcare properties that serve hospitals, health systems and other healthcare providers. Its business model centers on securing long-term, triple-net leases to generate stable income streams from a diversified tenant base.
The company’s properties are located across key metropolitan markets in the United States, including major healthcare hubs in the Southeast, Southwest and in select coastal regions.
Read More
- Five stocks we like better than Healthcare Realty Trust
- Chevron’s Strong Quarter Shows Why It Still Leads the Energy Sector
- Amazon’s Earnings Beat Shows Why AWS Is Back at the Center of the Bull Case
- Apple’s Record Quarter Could Not Outrun Its Guidance Problem
- McKesson’s Compounding Keeps Adding Up
Receive News & Ratings for Healthcare Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthcare Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.
